Decellularized xenogenic cartilage extracellular matrix (ECM) scaffolds made from goat auricular cartilage repaired rabbit osteochondral defects over 3 months, but the source study evaluated repair only qualitatively (representative micro-CT and histology), never measured the mechanical strength of the regenerated tissue, could not establish whether fully functional native cartilage with a zonal hierarchy was restored, and was confined to small defects in rabbits. The open problem is whether this cell-free xenogenic cartilage-ECM scaffold family can achieve genuinely functional osteochondral restoration — demonstrated through statistically powered quantitative imaging endpoints, direct biomechanical measurement of the regenerated tissue, and evidence of zonal cartilage organization — and whether the effect holds in larger, load-bearing defects in larger animals such as pigs or dogs. Available 2022–2026 studies report partial progress on individual axes (quantitative micro-CT and motor-function endpoints in rats; indentation-tested, zonally recellularized cell-seeded decellularized osteochondral plugs in goats), but none delivers the combined functional validation for the cell-free cartilage-ECM scaffold family, and the gaps remain unaddressed through early 2026.

Background

An osteochondral defect is a lesion that penetrates both the articular cartilage (the low-friction load-bearing surface of a joint) and the underlying subchondral bone; such defects arise from trauma and osteochondritis dissecans (a condition in which the bone beneath a joint surface loses its blood supply and separates together with the overlying cartilage) and commonly progress toward early osteoarthritis because articular cartilage has negligible self-repair capacity. Clinical options such as microfracture, osteochondral autograft transfer, and autologous chondrocyte implantation each have limits (donor-site morbidity, fibrocartilage rather than hyaline repair, cost, and two-stage surgery), which motivates tissue-engineered alternatives. One such alternative is the decellularized extracellular matrix (dECM) scaffold: cartilage harvested from a donor of another species (xenogenic) is chemically stripped of its cells — here with hypotonic–hypertonic buffers or the detergent Triton X-100 — so that the residual collagen- and glycosaminoglycan-rich ECM remains as a cell-free, immunologically dampened matrix intended to recruit and guide the recipient's own cells. 'Cell-free' means no donor or cultured cells are implanted; the scaffold must recruit host cells (potentially mesenchymal stem/stromal cells, connective-tissue progenitors capable of differentiating toward cartilage and bone lineages) by itself, sometimes aided by a growth factor such as insulin-like growth factor 1 (IGF-1), a protein that promotes chondrocyte survival and cartilage matrix synthesis. The source study (Das et al., J. Mater. Chem. B 2021, DOI 10.1039/d1tb00314c) decellularized goat conchal (auricular) cartilage, verified biocompatibility and chondrogenic support in vitro with C3H10T1/2 mesenchymal cells and in rabbit subcutaneous implants, and then implanted the scaffolds, with and without IGF-1, in rabbit knee osteochondral defects for 3 months, assessing repair by histology and micro-CT (micro-computed tomography, an X-ray technique producing 3D images of bone and, with contrast or edge detection, soft-tissue structure). Native articular cartilage is not homogeneous: it has a zonal hierarchy — a superficial zone with flat, lubricating cells, a middle zone of rounded cells in a proteoglycan-rich matrix, and a deep calcified zone anchoring to subchondral bone — and restoration of this layered organization, not mere defect filling, is what distinguishes functional hyaline cartilage from mechanically inferior fibrocartilage. The authors themselves flagged what remained unresolved: the micro-CT findings were representative and qualitative rather than statistically significant quantitative outcomes; the mechanical strength of the regenerated constructs was never monitored, so load-bearing quality is unverified; complete restoration of fully functional native cartilage with zonal hierarchy was explicitly described as unclear; and larger knee defects in larger animals such as pigs or dogs were proposed as the necessary next step, since the rabbit model imposes small, lightly loaded defects that cannot establish translational load-bearing performance.

Problem Statement

Determine whether cell-free decellularized xenogenic cartilage-ECM scaffolds (as exemplified by the goat auricular cartilage scaffolds, with or without IGF-1, of Das et al. 2021) can produce genuinely functional osteochondral restoration, jointly evidenced by: (1) statistically powered quantitative imaging outcomes of bone and cartilage regeneration, rather than representative qualitative micro-CT; (2) direct biomechanical measurement of the regenerated osteochondral tissue, establishing its load-bearing quality; (3) histological and functional demonstration of whether fully functional native articular cartilage with its zonal hierarchy (superficial, middle, and calcified zones) is restored, as opposed to fibrocartilaginous defect filling; and (4) confirmation of the effect in larger knee defects in larger animals such as pigs or dogs, where joint loading approaches a translational scale. A definitive negative result — demonstrating at this standard that such restoration is not achieved — would equally answer the question. These four items are one coherent objective: replacing qualitative small-animal defect-filling evidence with functional, load-bearing, quantitatively validated restoration evidence for the cell-free xenogenic cartilage-ECM scaffold family.

References

  1. Das, Piyali; Mishra, Rutusmita; Devi, Bavya; Rajesh, Kanike; Basak, Piyali; Roy, Mangal; Roy, Partha; Lahiri, Debrupa; Nandi, Samit Kumar (2021). Decellularized xenogenic cartilage extracellular matrix (ECM) scaffolds for the reconstruction of osteochondral defects in rabbits. Journal of Materials Chemistry B 9(24):4873–4894. DOI: 10.1039/d1tb00314c. https://doi.org/10.1039/d1tb00314c
  2. Wei, Yuxuan; Liao, Hanbin; Guo, Hao; Li, Zhifu; Zhao, Jiebing; Yeung, Kelvin Wai Kwok; Chen, Shixuan; Zeng, Canjun (2026). Biomimetic mineralized xenogenic acellular cartilage matrix promotes the repair of osteochondral defects and the recovery of motor function. Biomaterials 326:123722. DOI: 10.1016/j.biomaterials.2025.123722. https://doi.org/10.1016/j.biomaterials.2025.123722
  3. Meng, Haoye; Liu, Xuejian; Liu, Ronghui; Zheng, Yudong; Hou, Angyang; Liu, Shuyun; He, Wei; Wang, Yu; Wang, Aiyuan; Guo, Quanyi; Peng, Jiang (2024). Decellularized laser micro-patterned osteochondral implants exhibit zonal recellularization and self-fixing for osteochondral regeneration in a goat model. Journal of Orthopaedic Translation 46:18–32. DOI: 10.1016/j.jot.2024.04.005. https://doi.org/10.1016/j.jot.2024.04.005
  4. Jia, Lijunpeng; Cheng, Junyi; Wen, Xing; Zhang, Ziwei; Bao, Hui; Fei, Juanjie; Ding, Zhipu; Li, Jingchi; Li, Zhonghan (2026). Acellular cartilage matrix scaffolds for cartilage regeneration: current progress and future directions. Journal of Materials Chemistry B 14(10):3048–3070. DOI: 10.1039/d6tb00068a. https://doi.org/10.1039/d6tb00068a
  5. Demmer, Wolfram; Schinacher, Jannik; Wiggenhauser, Paul Severin; Giunta, Riccardo E. (2024). Use of Acellular Matrices as Scaffolds in Cartilage Regeneration: A Systematic Review. Advances in Wound Care 13(12):625–638. DOI: 10.1089/wound.2024.0065. https://doi.org/10.1089/wound.2024.0065
  6. Aswathy, S. H.; Narendrakumar, U.; Manjubala, I. (2025). An Overview of Approaches and Evaluation Methods for Tissue-Engineered Articular Cartilage Constructs in Animal Models. Annals of Biomedical Engineering 53(11):3009–3030. DOI: 10.1007/s10439-025-03819-7. https://doi.org/10.1007/s10439-025-03819-7
  7. Sani, Mahsa; Hosseinie, Radmarz; Latifi, Mona; Shadi, Mehri; Razmkhah, Mahboobeh; Salmannejad, Mahin; Parsaei, Hossein; Talaei-Khozani, Tahereh (2022). Engineered artificial articular cartilage made of decellularized extracellular matrix by mechanical and IGF-1 stimulation. Biomaterials Advances 139:213019. DOI: 10.1016/j.bioadv.2022.213019. https://doi.org/10.1016/j.bioadv.2022.213019